Vitreopapillary and vitreomacular traction in proliferative Eales' disease
نویسندگان
چکیده
منابع مشابه
Vitreopapillary traction in proliferative diabetic vitreoretinopathy
Aim—To present the clinical profile of a new entity in advanced proliferative diabetic vitreoretinopathy (PDVR). Mechanisms of vision loss due to vitreopapillary traction on the nasal optic disc are described, followed by an introduction of methods for prevention and treatment in such cases. Methods—17 patients with PDVR and traction on the nasal side of the optic disc, pallor of the optic nerv...
متن کاملVitreomacular traction syndrome
DOI: 10.1590/S1679-45082015AI2979 NRS, a woman, 71-year-old, who born in São Paulo, Brazil, sought our care service complaining of progressive low visual and metamorphopsia in the right eyes (RE) for 3 months. She had no-history of comorbidities, ophthalmologic surgeries or eye diseases. Upon examination her best-corrected visual acuity was 20/80 in the RE and 20/20 in the left eye. Funduscopy ...
متن کاملVitreomacular Traction Syndrome
The advent of new technologies such as high definition optical coherence tomography (OCT) has not only provided unprecedented imaging capabilities, but also raised the need to define concepts not yet settled and often confusing such as the vitreomacular traction (VMT) syndrome. While technological advances drive us into the future by clarifying the pathophysiology of many diseases and enabling ...
متن کاملVitreopapillary traction confirmed by optical coherence tomography.
1. Hardman JG, Limbird L, Gilman AG. The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill; 2001. 2. Coulter DM, Clark DWJ, Savage RL. Celecoxib, rofecoxib, and acute temporary visual impairment. BMJ. 2003;327:1214-1215. 3. Lund BC, Neiman RF. Visual disturbance associated with celecoxib. Pharmacotherapy. 2001; 21:114-115. 4. Edwards IR, Biriell C. Harmonisation in pharm...
متن کاملPneumo-Enzymatic Vitreolysis for Resistant Vitreomacular Traction
Aim: Case report describing a patient with resistant vitreomacular traction (VMT) treated with an intravitreal injection of a potentially safer, lower dose of ocriplasmin and with a residual intravitreal gas bubble from pneumatic vitreolysis. Case Report: An 88-year-old man with symptomatic vitreomacular traction (VMT) was observed for 4 weeks without spontaneous release. Pneumatic vitreolysis ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Case Reports
سال: 2012
ISSN: 1757-790X
DOI: 10.1136/bcr-2012-007231